Cargando…
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed wit...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196466/ https://www.ncbi.nlm.nih.gov/pubmed/32107877 http://dx.doi.org/10.1002/mgg3.1193 |
_version_ | 1783528730979729408 |
---|---|
author | Huang, Hui Xiong, Ying Wu, Zhensheng He, Yuhui Gao, Xianglin Zhou, Zhangyan Wang, Tao |
author_facet | Huang, Hui Xiong, Ying Wu, Zhensheng He, Yuhui Gao, Xianglin Zhou, Zhangyan Wang, Tao |
author_sort | Huang, Hui |
collection | PubMed |
description | BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed with the quantitative real‐time PCR method. Cell counting kit‐8 assay, colony formation assay, wound‐healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR‐138‐5P. RESULTS: We showed MIR‐138‐5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR‐138‐5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR‐138‐5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR‐138‐5P on PCa cell behaviors. CONCLUSIONS: Collectively, we showed that MIR‐138‐5P functions as a tumor suppressor gene in PCa via targeting FOXC1. |
format | Online Article Text |
id | pubmed-7196466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71964662020-05-04 MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1 Huang, Hui Xiong, Ying Wu, Zhensheng He, Yuhui Gao, Xianglin Zhou, Zhangyan Wang, Tao Mol Genet Genomic Med Original Articles BACKGROUND: Studies have suggested that micro‐RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR‐138‐5P (613394) in prostate cancer (PCa) remains unclear. METHODS: Expression level of MIR‐138‐5P in PCa cell lines and normal cell line was analyzed with the quantitative real‐time PCR method. Cell counting kit‐8 assay, colony formation assay, wound‐healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR‐138‐5P. RESULTS: We showed MIR‐138‐5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR‐138‐5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR‐138‐5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR‐138‐5P on PCa cell behaviors. CONCLUSIONS: Collectively, we showed that MIR‐138‐5P functions as a tumor suppressor gene in PCa via targeting FOXC1. John Wiley and Sons Inc. 2020-02-28 /pmc/articles/PMC7196466/ /pubmed/32107877 http://dx.doi.org/10.1002/mgg3.1193 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Huang, Hui Xiong, Ying Wu, Zhensheng He, Yuhui Gao, Xianglin Zhou, Zhangyan Wang, Tao MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1 |
title |
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
|
title_full |
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
|
title_fullStr |
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
|
title_full_unstemmed |
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
|
title_short |
MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1
|
title_sort | mir‐138‐5p inhibits the progression of prostate cancer by targeting foxc1 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196466/ https://www.ncbi.nlm.nih.gov/pubmed/32107877 http://dx.doi.org/10.1002/mgg3.1193 |
work_keys_str_mv | AT huanghui mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT xiongying mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT wuzhensheng mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT heyuhui mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT gaoxianglin mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT zhouzhangyan mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 AT wangtao mir1385pinhibitstheprogressionofprostatecancerbytargetingfoxc1 |